A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...

Researchers have created a highly detailed cellular map of Alzheimer’s disease progression, revealing new insights into the ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

An analysis of brains at various stages of Alzheimer's found that neurons called inhibitory neurons are the first to be affected by the disease.

The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...

Too often, people learn they have Alzheimer’s disease (AD) when it’s too late. The changes in the brain that lead to AD ...

INmune Bio, Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

A study of cells from 84 brains finds that Alzheimer's has two distinct phases, and that one type of neuron is especially ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

If you've been looking for a sign to work on your sleep hygiene, this is it. A new study suggests that a particular wave of ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.